GILD | Gilead Sciences
60.74 -0.44 (-0.72%)
GILD Price Profile
Open
$60.58
CLOSE
$60.74
DAY RANGE
60.31 - 61.18
52 WEEK RANGE
57.19 - 74.12
MARKET CAP
84.22B
Trading volume
8.16M
Prev. Close
61.18
50 Day MA
70.57
Shares Outstanding
1.25B
Public Float
1.25B
Average Volume
8.29M
Beta
0.36
PEG Ratio
6.35
Shares Shorted
21.3M
% OF SHARES SHORTED
1.70%
Short Ratio
2.91
1 Year Performance
5.13%
Diluted EPS (TTM)
5.84
Q Revenue Growth
0.13
Ebitda
14.93B
Gross Profit (TTM)
21B
Total Cash (MRQ)
6.61B
Total Debt (MRQ)
27.69B
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Gilead Sciences (GILD) company profile
Gilead Sciences Inc. (NASDAQ: GILD) is a biopharmaceutical company that researches, develops, and commercializes medicines. The company focuses on advancing medicines to prevent and treat diseases like human immunodeficiency virus (HIV), viral hepatitis, and cancer. The company has existing collaboration with Arcus Biosciences, Pionyr; Tizona; Tango Therapeutics, Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S.
